FibroBiologics, Inc. — Form D

FibroBiologics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-16. The offering totals $1.7M, of which $1.7M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2025-12-16
• Form: D
• Accession: 0001493152-25-028000
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $1.7M
• Amount sold: $1.7M
• Investors: 4
• Date of first sale: 2025-12-14
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-567052

Issuer

• Name: FibroBiologics, Inc.
• CIK: 0001958777
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 9350 KIRBY DRIVE SUITE 300, HOUSTON, TX, 77054
• Phone: 281-671-5150

Officers, directors & promoters (14)

Other filings by this issuer (3)

More

• CIK 1958777 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search